Sensex and Nifty Performance Overview

After opening sharply lower by 532.83 points, the Sensex extended its losses throughout the day, closing below its 50-day moving average (DMA). Notably, the 50 DMA itself is trading below the 200 DMA, signalling a bearish technical setup that may weigh on near-term market momentum. The Nifty mirrored this weakness, dragged down by a majority of sectors and large-cap stocks.

Midcap and smallcap indices also succumbed to selling pressure, with the S&P BSE 150 Midcap Index falling 0.16% and the S&P BSE 250 Smallcap Index declining 0.12%. The broader BSE 100 index was down 0.71%, reflecting a widespread risk-off mood among investors.

Sectoral Trends: Divergence Amidst Weakness

Out of 38 sectors tracked on the BSE, only seven managed to close in positive territory, while 31 sectors declined. The Nifty Pharma sector emerged as the top gainer, advancing 2.08%, buoyed by strong performances from key pharmaceutical stocks. In contrast, the Nifty Auto sector was the worst performer, dropping 1.88%, pressured by subdued demand outlook and global supply chain concerns.

Capital goods and power sectors stood out with notable strength, as the S&P BSE Capital Goods and S&P BSE Power indices, along with Nifty Energy, hit new 52-week highs during the session. This resilience was driven by optimism around infrastructure spending and energy demand recovery.

Market Breadth and Stock Movers

The advance-decline ratio across the BSE 500 index was weak at 0.56x, with 178 stocks advancing against 319 declining. This negative breadth underscores the cautious stance of market participants amid mixed earnings expectations and global uncertainties.

Among the top gainers on the BSE 500, Piramal Pharma led with an impressive 8.84% surge, followed by OneSource Speciality Chemicals at 7.44% and Dr Reddy's Laboratories, which gained 7.06%. Dr Reddy's also topped the large-cap gainers list, while Oracle Financial Services led midcaps with a 7.06% rise. Piramal Pharma was the standout small-cap gainer.

On the downside, Havells India was the largest large-cap loser, falling 6.21%, weighed down by profit booking and sector rotation. IIFL Finance declined 6.18%, marking the biggest loss among small caps, while Ashok Leyland was the top mid-cap laggard, down 3.30%. Krishna Institute also fell sharply by 5.30%.

Foreign and Domestic Institutional Activity

Foreign institutional investors (FIIs) remained net sellers, continuing their cautious stance amid global uncertainties and mixed economic data from major economies. Domestic institutional investors (DIIs), however, showed selective buying interest, particularly in defensive sectors such as pharmaceuticals and power, which helped limit the downside.

This divergence in institutional flows contributed to the uneven sectoral performance and the overall subdued market breadth.

Global Cues and Their Impact

Global markets were mixed, with US indices showing modest gains while European and Asian markets traded lower. Concerns over inflationary pressures, central bank policy tightening, and geopolitical tensions kept investors cautious. These factors influenced the Indian market’s risk appetite, leading to profit-taking in cyclical sectors and a flight to quality in defensive stocks.

Commodity prices, particularly crude oil, remained volatile, impacting energy and auto sectors. The resilience in capital goods and power sectors was partly driven by expectations of government stimulus and infrastructure investments aimed at boosting economic growth.

Upcoming Corporate Earnings to Watch

Investor focus is shifting towards key earnings announcements scheduled for 24 Apr 2026, including Reliance Industries, Shriram Finance, and Hindustan Zinc. These results are expected to provide further direction to the market, especially given Reliance’s significant weight in the indices and its diversified business model.

Market participants will closely analyse these earnings for cues on demand trends, margin pressures, and capital expenditure plans amid a challenging macroeconomic environment.

Technical Outlook and Market Sentiment

The technical landscape remains cautious as the Sensex trades below its 50 DMA, which itself is positioned below the 200 DMA, a classic bearish crossover signalling potential further downside. The lack of broad-based sector participation and weak market breadth reinforce this cautious stance.

However, pockets of strength in pharma, capital goods, and power sectors suggest selective opportunities for investors focusing on quality and defensive themes. The upcoming earnings season will be critical in shaping market direction, with investors likely to favour companies demonstrating resilient earnings growth and robust balance sheets.

Conclusion

In summary, the Indian equity market experienced a broad-based correction on 23 Apr 2026, driven by mixed global cues, cautious institutional flows, and sectoral divergence. While the Sensex and Nifty indices declined by around 0.8%, defensive sectors like pharmaceuticals and infrastructure-related segments showed resilience. Market participants should remain vigilant ahead of key corporate earnings and global developments, adopting a selective approach to stock picking amid ongoing volatility.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →